News

Decoy increases effectiveness of treatment in B-cell acute lymphoblastic leukaemia B-cell Acute Lymphoblastic Leukaemia ...
Monoclonal antibodies (Mabs) conjugated to toxins or their subunits (immunotoxins or ITs) are undergoing clinical testing in adults with a variety of malignancies. The potential impact of this ...
Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...
Explore the impact of functional respiratory tests on outcomes in anti-CD19 CAR T-cell therapy, presented at EBMT 2025.
“We’re advancing REC-3565, a potential best-in-class MALT1 inhibitor, to improve outcomes for patients with B-cell malignancies with limited treatment options,” said David Mauro, Chief Medical Officer ...
This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.
A cell phone sold on Facebook marketplace wound up at the centre of a BC Civil Resolution Tribunal case after it was ...
When contact with other cells is made, the pre-junctions begin to mature and form ... More information: Regina B. Troyanovsky et al, Actin-dependent α-catenin oligomerization contributes to ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
Chad Horner of Oliveburg has announced his candidacy for reelection to the Punxsutawney Area School Board. He was first ...
A new study published in Nature Cardiovascular Research found that while carotid artery narrowing can lead to stroke in both ...